Comprehensive Psychiatry
Volume 45, Issue 2 , Pages 88-94 , March 2004

Determination of the main risk factors for benzodiazepine dependence using a multivariate and multidimensional approach

  • Cornelis C Kan

      Affiliations

    • Department of Psychiatry, University Medical Centre St. Radboud, Nijmegen, The Netherlands
    • Corresponding Author InformationAddress reprint requests to Cornelis C. Kan, M.D, Ph.D, University Medical Centre St. Radboud, Department of Psychiatry, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Sander R Hilberink

      Affiliations

    • Department of Psychiatry, University Medical Centre St. Radboud, Nijmegen, The Netherlands
    • ,
  • Marinus H.M Breteler

      Affiliations

    • Department of Clinical Psychology, University of Nijmegen, Nijmegen, The Netherlands

References 

  1. Barnas C, Whitworth AB, Fleischhacker WW. Are patterns of benzodiazepine use predictable? A follow-up study of benzodiazepine users. Psychopharmacology (Berl). 1993;111:301–305
  2. Bixler EO, Kales JD, Kales A, Jacoby JA, Soldatos CR. Rebound insomnia and elimination half-life (assessment of individual subject response). J Clin Pharmacol. 1985;25:115–124
  3. Busto U, Sellers EM, Naranjo CA, Cappell H, Sanchez Craig M, Sykora K. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med. 1986;315:854–859
  4. Golombok S, Higgitt A, Fonagy P, Dodds S, Saper J, Lader M. A follow-up study of patients treated for benzodiazepine dependence. Br J Med Psychol. 1987;60:141–149
  5. Hallstrom C, Lader M. Benzodiazepine withdrawal phenomena. Int Pharmacopsychiatry. 1981;16:235–244
  6. Hellerstein DJ, Flansaas DM, Zweben-Howland LD, Samstag LW. A clinical profile of patients affected by state regulation of benzodiazepine prescriptions. Hosp Community Psychiatry. 1994;45:362–365
  7. Holton A, Riley P, Tyrer P. Factors predicting long-term outcome after chronic benzodiazepine therapy. J Affect Disord. 1992;24:245–252
  8. Kales A, Scharf MB, Kales JD, Soldatos CR. Rebound insomnia (A potential hazard following withdrawal of certain benzodiazepines). JAMA. 1979;241:1692–1695
  9. las-Cuevas C, Sanz EJ, de la Fuente JA, Padilla J, Berenguer JC. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence (SDS validation study). Addiction. 2000;95:245–250
  10. Linden M, Bar T, Geiselmann B. Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions. Psychol Med. 1998;28:721–729
  11. Murphy SM, Tyrer P. A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. Br J Psychiatry. 1991;158:511–516
  12. Rickels K, Schweizer E, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines: I. Effects of abrupt discontinuation. Arch Gen Psychiatry. 1990;47:899–907
  13. Schweizer E, Case WG, Rickels K. Benzodiazepine dependence and withdrawal in elderly patients. Am.J.Psychiatry. 1989;146:529–531
  14. Schweizer E, Rickels K, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines: II. Effects of gradual taper. Arch Gen Psychiatry. 1990;47:908–915
  15. Schweizer E, Rickels K, De Martinis N, Case G, Garcia-Espana F. The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients. Psychol Med. 1998;28:713–720
  16. Tyrer P, Rutherford D, Huggett T. Benzodiazepine withdrawal symptoms and propranolol. Lancet. 1981;1:520–522
  17. Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after long-term therapy. Lancet. 1983;1:1402–1406
  18. Joughin N, Tata P, Collins M, Hooper C, Falkowski J. In-patient withdrawal from long-term benzodiazepine use. Br J Addict. 1991;86:449–455
  19. Nicholas D, Hammond SM. Personality characteristics of long-term benzodiazepine users. Pers Individ Differ. 1992;13:221–223
  20. Holm L, Bergman H, Borg S. Personality characteristics of patients with exclusive abuse of sedative-hypnotic drugs. Psychol Rep. 1982;51:899–903
  21. Rickels K, Case GW, Winokur A, Swenson C. Long-term benzodiazepine therapy (benefits and risks). Psychopharmacol Bull. 1984;20:608–615
  22. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. Ed 3. Rev. Washington, DC: American Psychological Association; 1987;
  23. American Psychiatric Association . Diagnostic and Statistical Manual for Mental Disorders (DSM-IV). Ed.4. Washington, DC: American Psychological Association; 1994;
  24. World Health Organization . The ICD-10 Classification of Mental and Behavioural Disorders (Diagnostic Criteria for Research). Geneva, Switzerland: WHO; 1992;
  25. Kan CC, Breteler MHM, van der Ven AHGS, Zitman FG. An evaluation of the DSM-III-R and ICD-10 benzodiazepine dependence criteria using Rasch modelling. Addiction. 1998;93:349–359
  26. Kan CC, Breteler MHM, Timmermans EAY, van der Ven AHGS, Zitman FG. Scalability, reliability and validity of the Benzodiazepine Dependence Self-Report Questionnaire in outpatient benzodiazepine users. Compr Psychiatry. 1999;40:283–291
  27. Kan CC, Breteler MH, van der Ven AH, Zitman FG. Cross-validation of the Benzodiazepine Dependence Self-Report Questionnaire in outpatient benzodiazepine users. Compr Psychiatry. 2001;42:433–439
  28. Kan CC, van der Ven AH, Breteler MH, Zitman FG. Latent trait standardization of the Benzodiazepine Dependence Self-Report Questionnaire using the Rasch scaling model. Compr Psychiatry. 2001;42:424–432
  29. Wolf B, Griffiths RR. Physical dependence on benzodiazepines (differences within the class). Drug Alcohol Depend. 1991;29:153–156
  30. Giel R, Nienhuis FJ. SCAN:Vragenschema”s voor de klinische beoordeling in de neuropsychiatrie. Geneva, Switzerland: World Health Organization; 1992;
  31. Janca A, Ustun TB, Sartorius N. New versions of World Health Organization instruments for the assessment of mental disorders. Acta Psychiatr Scand. 1994;90:73–83
  32. Arrindell WA, Ettema H. Dimensionele structuur, betrouwbaarheid en validiteit van de Nederlandse bewerking van de Symptom Checklist (SCL-90) (Gegevens gebaseerd op een fobische en een “normale” populatie). Nederlands Tijdschr Psychol Grensgebieden. 1981;36:77–108
  33. Kan CC, Breteler MHM, Zitman FG. High prevalence of benzodiazepine dependence in outpatient users, based on the DSM-III-R and ICD-10 criteria. Acta Psychiatr Scand. 1997;96:85–93
  34. Kan CC, Breteler MH, van der Ven AH, Timmermans MA, Zitman FG. Assessment of benzodiazepine dependence in alcohol and drug dependent outpatients (a research report). Subst Use Misuse. 2001;36:1085–1109

☆ This study was entirely funded by the University Medical Centre St. Radboud Nijmegen.

PII: S0010-440X(03)00221-9

doi: 10.1016/j.comppsych.2003.12.007

Comprehensive Psychiatry
Volume 45, Issue 2 , Pages 88-94 , March 2004

Article Tools